Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes.
BACKGROUND
Coronary artery calcification (CAC) is more severe and occurs at an earlier age in type 1 diabetes. Risk factors for this subclinical marker of atherosclerotic burden, like coronary artery disease (CAD) itself, are not fully identified. One postulated mechanism for the increased CAC observed in type 1 diabetes is the accumulation of advanced glycation end products (AGEs). As certain collagen AGEs fluoresce, skin intrinsic fluorescence (SIF) can act as a novel marker of levels of collagen AGEs. We thus sought to determine the relationship between skin intrinsic fluorescence and CAC in type 1 diabetes.


METHODS
One hundred five participants in the Pittsburgh Epidemiology of Diabetes Complications study of childhood-onset (age <17 years) type 1 diabetes who had previously undergone electron beam tomography scanning for CAC (80 of whom had follow-up data) had SIF measurements taken using the SCOUT DM (VeraLight, Inc., Albuquerque, NM). Mean age and diabetes' duration were 49 and 40 years, respectively, at the time of SIF measurement.


RESULTS
Seventy-one percent of the study participants had some measurable CAC that was univariately (but not after age adjustment) cross-sectionally associated with SIF (odds ratio = 2.51, 1.37-4.59). However, for CAC severity using natural logarithmically transformed scores, SIF was both univariately (P < 0.0001) and multivariably (P = 0.03) associated with CAC. This relationship was independent of age, a history of CAD, renal function, or renal damage. Receiver operator characteristic analyses revealed that the discriminative ability of SIF to detect CAC went from an area under the curve of 71% for the presence of any CAC to 85% for those with a CAC score >400.


CONCLUSIONS
The relationship between SIF and CAC appears stronger with more severe calcification. Given the strong relationship of CAC with CAD this finding has important implications and suggests that SIF maybe a useful marker of CAC/CAD risk and potentially a therapeutic target.
Conway
Baqiyyah
B
Vanderbilt Epidemiology Center, Vanderbilt University , Nashville, Tennessee, USA.
Edmundowicz
Daniel
D
Matter
Nathaniel
N
Maynard
John
J
Orchard
Trevor
T
D000328:Adult; D002114:Calcinosis / Q000473:pathology*; D003324:Coronary Artery Disease / Q000473:pathology*; D003922:Diabetes Mellitus, Type 1 / Q000473:pathology*; D003925:Diabetic Angiopathies / Q000473:pathology*; D005260:Female; D005453:Fluorescence; D006801:Humans; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis; D012720:Severity of Illness Index; D012867:Skin; D013050:Spectrometry, Fluorescence
Diabetes Care. 1990 Jul;13(7):741-7
2387194
Diab Vasc Dis Res. 2007 Dec;4(4):332-9
18158704
N Engl J Med. 2008 Mar 27;358(13):1336-45
18367736
Diabetes Care. 1994 Nov;17(11):1252-6
7821163
J Vasc Res. 2003 Nov-Dec;40(6):567-74
14691339
Diabetologia. 2009 May;52(5):789-97
19274450
Diabetes. 1990 Sep;39(9):1116-24
2384191
Diabetes Care. 2007 May;30(5):1120-4
17337498
J Am Coll Cardiol. 2000 Oct;36(4):1253-60
11028480
Radiology. 1998 Sep;208(3):807-14
9722864
Metabolism. 2006 Dec;55(12):1689-96
17142145
Diabetologia. 2009 Apr;52(4):705-14
19183936
Cell Mol Biol (Noisy-le-grand). 1998 Nov;44(7):1081-94
9846890
Diabetologia. 1983 May;24(5):347-50
6873514
J Diabetes Sci Technol. 2009 Jul 01;3(4):776-80
20144328
Biochem Biophys Res Commun. 1999 May 10;258(2):353-7
10329391
Clin Chem. 1978 Jun;24(6):900-4
207462
Mayo Clin Proc. 1999 Mar;74(3):243-52
10089993
N Engl J Med. 1991 Sep 19;325(12):836-42
1875967
Diabetologia. 2004 Jul;47(7):1324-1330
15243705
Diabetologia. 1996 Mar;39(3):298-305
8721775
Diabetes. 1999 Apr;48(4):870-80
10102706
Kidney Int. 2006 Jul;70(1):218-24
16723988
Lancet. 1994 Jun 18;343(8912):1519-22
7911868
Clin Chem. 1974 Apr;20(4):470-5
4818200
J Biol Chem. 2000 Dec 15;275(50):39027-31
10976109
Circulation. 1995 Mar 1;91(5):1363-7
7867174
AJR Am J Roentgenol. 2004 May;182(5):1327-32
15100140
Diabetes. 2000 Sep;49(9):1571-8
10969842
Br Med J (Clin Res Ed). 1982 Mar 27;284(6320):928-30
6802354
Curr Diabetes Rev. 2005 Feb;1(1):93-106
18220586
Circulation. 2000 Feb 29;101(8):850-5
10694523
Diabetes. 2003 Nov;52(11):2833-9
14578303
Opt Express. 2004 Sep 20;12(19):4496-510
19484001